CervoMed Inc. CRVO
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -15.84% | -11.92% | |||
| Gross Profit | 15.84% | 11.79% | |||
| SG&A Expenses | -20.78% | 18.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.65% | -2.75% | |||
| Operating Income | 17.65% | 2.65% | |||
| Income Before Tax | 17.48% | 1.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.48% | 1.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.48% | 1.52% | |||
| EBIT | 17.65% | 2.65% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 25.42% | 1.56% | |||
| Normalized Basic EPS | 25.43% | 1.56% | |||
| EPS Diluted | 25.42% | 1.56% | |||
| Normalized Diluted EPS | 25.43% | 1.56% | |||
| Average Basic Shares Outstanding | 10.65% | 0.04% | |||
| Average Diluted Shares Outstanding | 10.65% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||